John Jed Kennedy - Nov 2, 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Group Executive Vice President
Signature
Sarah M. Oliker for John (Jed) Kennedy by Power of Attorney
Stock symbol
CNMD
Transactions as of
Nov 2, 2021
Transactions value $
-$747,153
Form type
4
Date filed
11/4/2021, 03:36 PM
Previous filing
Aug 31, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $36.1K +862 +11.69% $41.93 8.24K Nov 2, 2021 Direct
transaction CNMD Common Stock Sale -$126K -862 -10.46% $146.67 7.38K Nov 2, 2021 Direct F1
transaction CNMD Common Stock Options Exercise $306K +5.1K +69.15% $59.96 12.5K Nov 2, 2021 Direct
transaction CNMD Common Stock Sale -$268K -1.82K -14.61% $147.06 10.7K Nov 2, 2021 Direct F2
transaction CNMD Common Stock Sale -$484K -3.28K -30.77% $147.57 7.38K Nov 2, 2021 Direct F3
transaction CNMD Common Stock Options Exercise $142K +1.8K +24.41% $78.76 9.18K Nov 2, 2021 Direct
transaction CNMD Common Stock Sale -$137K -928 -10.11% $147.51 8.25K Nov 2, 2021 Direct F4
transaction CNMD Common Stock Sale -$129K -872 -10.57% $148.31 7.38K Nov 2, 2021 Direct F5
transaction CNMD Common Stock Options Exercise $166K +1.7K +23.05% $97.69 9.08K Nov 2, 2021 Direct
transaction CNMD Common Stock Sale -$253K -1.7K -18.73% $148.60 7.38K Nov 2, 2021 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -862 -14.7% $0.00 5K Nov 2, 2021 Common Stock 862 $41.93 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5.1K -32.08% $0.00 10.8K Nov 2, 2021 Common Stock 5.1K $59.96 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1.8K -24% $0.00 5.7K Nov 2, 2021 Common Stock 1.8K $78.76 Direct F8
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1.7K -18.28% $0.00 7.6K Nov 2, 2021 Common Stock 1.7K $97.69 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.24 to $147.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.34 to $147.31. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.36 to $147.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.94 to $147.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.02 to $148.59. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.10 to $148.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F7 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F8 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period